Human epidermal growth factor receptor 2 (HER2/ErbB2), a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in several human cancers, including 20-25% of breast cancer (BC) cases and 10-30% of GC cases [6]. This evidence concerns the gene ERBB2 and breast cancer.